Flow cytometric analysis showed that DLL1 overexpression alone increased intratumoral CD8+ T cells, and EO771-L1 tumor with LNT treatments had the highest percentage of intratumoral CD8+ T cells (Fig. 2). This evidence concerns the gene CD8A and neoplasm.